1. Home
  2. Pharma & Healthcare
  3. Global Pneumococcal Vaccine Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Pneumococcal Vaccine Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 128 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Pneumococcal Vaccine market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Pneumococcal Vaccine market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Pneumococcal Vaccine in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
PPSV 23
PCV 7/13
PCV 10

Market Snapshot, By Application
Child
Adult

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Sanofipasteur
Pfizer
MSD
GSK
CDIBP

The study objectives of this report are:
To study and analyze the global Pneumococcal Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Pneumococcal Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Pneumococcal Vaccine manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pneumococcal Vaccine market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pneumococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pneumococcal Vaccine are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Pneumococcal Vaccine Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Pneumococcal Vaccine Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Pneumococcal Vaccine

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Pneumococcal Vaccine Sales Channel and Distributors Analysis
3.3.1 Pneumococcal Vaccine Sales Channel
3.3.2 Pneumococcal Vaccine Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Pneumococcal Vaccine Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Pneumococcal Vaccine Type Introduction
4.1.1 PPSV 23
4.1.2 PCV 7/13
4.1.3 PCV 10
4.2 Global Pneumococcal Vaccine Sales by Type 2016-2021
4.3 Global Pneumococcal Vaccine Revenue by Type 2016-2021
4.4 Global Pneumococcal Vaccine Price by Type 2016-2021

5 Market Segment: by Application
5.1 Pneumococcal Vaccine Type Introduction
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Sales by Application 2016-2021
5.3 Global Pneumococcal Vaccine Revenue by Application 2016-2021
5.4 Global Pneumococcal Vaccine Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Pneumococcal Vaccine Market by Region
6.1.1 Global Pneumococcal Vaccine Sales by Regions
6.1.2 Global Pneumococcal Vaccine Revenue by Regions
6.2 North America Pneumococcal Vaccine Market 2016-2021
6.3 Europe Pneumococcal Vaccine Market 2016-2021
6.4 Asia Pacific Pneumococcal Vaccine Market 2016-2021
6.5 South America Pneumococcal Vaccine Market 2016-2021
6.6 Middle East and Africa Pneumococcal Vaccine Market 2016-2021

7 North America
7.1 North America Pneumococcal Vaccine Market by Country 2016-2021
7.1.1 North America Pneumococcal Vaccine Sales by Country
7.1.2 North America Pneumococcal Vaccine Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Pneumococcal Vaccine Market by Country 2016-2021
8.1.1 Europe Pneumococcal Vaccine Sales by Country
8.1.2 Europe Pneumococcal Vaccine Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Pneumococcal Vaccine Market by Country 2016-2021
9.1.1 Asia Pacific Pneumococcal Vaccine Sales by Country
9.1.2 Asia Pacific Pneumococcal Vaccine Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Pneumococcal Vaccine Market by Country 2016-2021
10.1.1 South America Pneumococcal Vaccine Sales by Country
10.1.2 South America Pneumococcal Vaccine Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Pneumococcal Vaccine Market by Country 2016-2021
11.1.1 Middle East and Africa Pneumococcal Vaccine Sales by Country
11.1.2 Middle East and Africa Pneumococcal Vaccine Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Sanofipasteur
12.1.1 Sanofipasteur Company Information
12.1.2 Sanofipasteur Pneumococcal Vaccine Product Portfolio, Specification and Application
12.1.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Sanofipasteur Key Development
12.2 Pfizer
12.2.1 Pfizer Company Information
12.2.2 Pfizer Pneumococcal Vaccine Product Portfolio, Specification and Application
12.2.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Pfizer Key Development
12.3 MSD
12.3.1 MSD Company Information
12.3.2 MSD Pneumococcal Vaccine Product Portfolio, Specification and Application
12.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 MSD Key Development
12.4 GSK
12.4.1 GSK Company Information
12.4.2 GSK Pneumococcal Vaccine Product Portfolio, Specification and Application
12.4.3 GSK Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 GSK Key Development
12.5 CDIBP
12.5.1 CDIBP Company Information
12.5.2 CDIBP Pneumococcal Vaccine Product Portfolio, Specification and Application
12.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 CDIBP Key Development

13 Global Pneumococcal Vaccine Market Forecast by Region by Type and by Application
13.1 Global Pneumococcal Vaccine Sales, Revenue Forecast 2022-2027
13.2 Global Pneumococcal Vaccine Forecast by Regions
13.2.1 Global Pneumococcal Vaccine Sales Forecast by Region 2022-2027
13.2.2 Global Pneumococcal Vaccine Revenue Forecast by Region 2022-2027
13.3 Global Pneumococcal Vaccine Forecast by Type
13.3.1 Global Pneumococcal Vaccine Sales Forecast by Type 2022-2027
13.3.2 Global Pneumococcal Vaccine Revenue Forecast by Type 2022-2027
13.3.3 Global Pneumococcal Vaccine Price Forecast by Type 2022-2027
13.4 Global Pneumococcal Vaccine Forecast by Application
13.4.1 Global Pneumococcal Vaccine Sales Forecast by Application 2022-2027
13.4.2 Global Pneumococcal Vaccine Revenue Forecast by Application 2022-2027
13.4.3 Global Pneumococcal Vaccine Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Pneumococcal Vaccine Production Specifications
Table 2: Drivers in Pneumococcal Vaccine Market
Table 3: Restraints Pneumococcal Vaccine Market
Table 4: Opportunity in Pneumococcal Vaccine Market
Table 5: Comparion of Alternative and Pneumococcal Vaccine
Table 6: Pneumococcal Vaccine Raw Materials Key Suppliers List
Table 7: Pneumococcal Vaccine Distributors List
Table 8: Pneumococcal Vaccine Major Buyers in Application One
Table 9: Pneumococcal Vaccine Major Buyers in Application Two
Table 10: Pneumococcal Vaccine Major Buyers in Application Three
Table 11: Global Pneumococcal Vaccine Sales (K Units) by Type 2016-2021
Table 12: Global Pneumococcal Vaccine Sales Market Share by Type 2016-2021
Table 13: Global Pneumococcal Vaccine Revenue (Million USD) by Type 2016-2021
Table 14: Global Pneumococcal Vaccine Revenue Market Share by Type 2016-2021
Table 15: Global Pneumococcal Vaccine Price by Type 2016-2021
Table 16: Global Pneumococcal Vaccine Sales (K Units) by Application 2016-2021
Table 17: Global Pneumococcal Vaccine Sales Market Share by Application 2016-2021
Table 18: Global Pneumococcal Vaccine Revenue (Million USD) by Application 2016-2021
Table 19: Global Pneumococcal Vaccine Revenue Market Share by Application 2016-2021
Table 20: Global Pneumococcal Vaccine Price by Application 2016-2021
Table 21: Global Pneumococcal Vaccine Sales (K Units) by Region 2016-2021
Table 22: Global Pneumococcal Vaccine Sales Market Share by Region 2016-2021
Table 23: Global Pneumococcal Vaccine Revenue (Million USD) by Region 2016-2021
Table 24: Global Pneumococcal Vaccine Revenue Market Share by Region 2016-2021
Table 25: North America Pneumococcal Vaccine Sales (K Units) by Country 2016-2021
Table 26: North America Pneumococcal Vaccine Sales Market Share by Country 2016-2021
Table 27: North America Pneumococcal Vaccine Revenue (Million USD) by Country 2016-2021
Table 28: North America Pneumococcal Vaccine Revenue Market Share by Country 2016-2021)
Table 29: Europe Pneumococcal Vaccine Sales (K Units) by Country 2016-2021
Table 30: Europe Pneumococcal Vaccine Sales Market Share by Country 2016-2021
Table 31: Europe Pneumococcal Vaccine Revenue (Million USD) by Country 2016-2021
Table 32: Europe Pneumococcal Vaccine Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Pneumococcal Vaccine Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Pneumococcal Vaccine Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Pneumococcal Vaccine Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Pneumococcal Vaccine Revenue Market Share by Country 2016-2021)
Table 37: South America Pneumococcal Vaccine Sales (K Units) by Country 2016-2021
Table 38: South America Pneumococcal Vaccine Sales Market Share by Country 2016-2021
Table 39: South America Pneumococcal Vaccine Revenue (Million USD) by Country 2016-2021
Table 40: South America Pneumococcal Vaccine Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Pneumococcal Vaccine Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Pneumococcal Vaccine Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country 2016-2021)
Table 45 Sanofipasteur Company Information
Table 46 Sanofipasteur Pneumococcal Vaccine Product Portfolio, Specification and Application
Table 47 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Pfizer Company Information
Table 49 Pfizer Pneumococcal Vaccine Product Portfolio, Specification and Application
Table 50 Pfizer Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 MSD Company Information
Table 52 MSD Pneumococcal Vaccine Product Portfolio, Specification and Application
Table 53 MSD Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 GSK Company Information
Table 55 GSK Pneumococcal Vaccine Product Portfolio, Specification and Application
Table 56 GSK Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 CDIBP Company Information
Table 58 CDIBP Pneumococcal Vaccine Product Portfolio, Specification and Application
Table 59 CDIBP Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Pneumococcal Vaccine Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Pneumococcal Vaccine Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Pneumococcal Vaccine Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Pneumococcal Vaccine Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Pneumococcal Vaccine Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Pneumococcal Vaccine Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Pneumococcal Vaccine Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Pneumococcal Vaccine Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Pneumococcal Vaccine Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Pneumococcal Vaccine Picture
Figure 2: Global Pneumococcal Vaccine Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Pneumococcal Vaccine Supply Chain Analysis
Figure 5: Pneumococcal Vaccine Manufacturing Cost Structure Analysis
Figure 6: Product Picture of PPSV 23
Figure 7: Product Picture of PCV 7/13
Figure 8: Global Pneumococcal Vaccine Sales Market Share by Type, 2020
Figure 9: Global Pneumococcal Vaccine Revenue Market Share by Type, 2020
Figure 10: Pneumococcal Vaccine in Child
Figure 11: Global Pneumococcal Vaccine Market: Child 2016-2021
Figure 12: Pneumococcal Vaccine in Adult
Figure 13: Global Pneumococcal Vaccine Market: Adult 2016-2021
Figure 14: Global Pneumococcal Vaccine Sales Market Share by Application, 2020
Figure 15: Global Pneumococcal Vaccine Revenue Market Share by Application, 2020
Figure 16: Global Pneumococcal Vaccine Sales Market Share by Region 2016-2021
Figure 17: Global Pneumococcal Vaccine Revenue Market Share by Region 2016-2021
Figure 18: North America Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 19: North America Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 20: Europe Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 21: Europe Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 24: South America Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 25: South America Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 28: North America Pneumococcal Vaccine Sales Market Share by Country, 2020
Figure 29: North America Pneumococcal Vaccine Revenue Market Share by Country, 2020
Figure 30: United States Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 31: United States Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 32: Canada Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 33: Canada Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 35: Mexico Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 36: Europe Pneumococcal Vaccine Sales Market Share by Country, 2020
Figure 37: Europe Pneumococcal Vaccine Revenue Market Share by Country, 2020
Figure 38: Germany Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 39: Germany Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 40: France Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 41: France Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 42: UK Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 43: UK Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 44: Italy Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 45: Italy Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 46: Russia Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 46: Russia Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 47: Spain Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 48: Spain Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Pneumococcal Vaccine Sales Market Share by Country, 2020
Figure 50: Asia Pacific Pneumococcal Vaccine Revenue Market Share by Country, 2020
Figure 51: China Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 52: China Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 53: Japan Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 54: Japan Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 55: Korea Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 56: Korea Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 59: India Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 60: India Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 61: Australia Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 62: Australia Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 63: South America Pneumococcal Vaccine Sales Market Share by Country, 2020
Figure 64: South America Pneumococcal Vaccine Revenue Market Share by Country, 2020
Figure 65: Brazil Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 66: Brazil Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 68: Argentina Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 70: Colombia Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country, 2020
Figure 73: Turkey Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 74: Turkey Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Pneumococcal Vaccine Sales (K Units) Status 2016-2021
Figure 78: South Africa Pneumococcal Vaccine Revenue (Million USD) Status 2016-2021
Figure 79: Sanofipasteur Pneumococcal Vaccine Revenue Market Share Globally (2019-2021)
Figure 80: Pfizer Pneumococcal Vaccine Revenue Market Share Globally (2019-2021)
Figure 81: MSD Pneumococcal Vaccine Revenue Market Share Globally (2019-2021)
Figure 82: GSK Pneumococcal Vaccine Revenue Market Share Globally (2019-2021)
Figure 83: CDIBP Pneumococcal Vaccine Revenue Market Share Globally (2019-2021)
Figure 89: Global Pneumococcal Vaccine Sales (K Units) Forecast (2022-2027)
Figure 90: Global Pneumococcal Vaccine Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets